PKY Share Price Performance
AU$0.025
0.01 (25.00%)
Price AU$0.025
Share PriceAU$0.025
Pathkey.AI Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PKY Community Narratives
There are no narratives available yet.
Recent PKY News & Updates
Pathkey.AI Ltd Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0048
- Gross Margin
- -95.47%
- Net Profit Margin
- -449.62%
- Debt/Equity Ratio
- -153.4%
Pathkey.AI Ltd Competitors
Snowflake Analysis
About PKY
- Founded
- 1994
- Employees
- n/a
- CEO
- WebsiteView website
Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Milsons Point, Australia.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Australian Market Performance
- 7 Days: 1.5%
- 3 Months: 5.4%
- 1 Year: 9.2%
- Year to Date: 9.7%
The market is up 1.5% over the last week, with the Materials sector leading the way, up 3.6%. As for the past 12 months, the market is up 9.2%. Looking forward, earnings are forecast to grow by 11% annually. Market details ›